The stamen exhibited high anti-Alzheimer’s disease activities through the inhibition of neurotransmitter degrading enzymes (cholinesterases) and β-amyloid formation enzyme (β-secretase) [3]. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.